Junctophilin-2 Expression Silencing Causes Cardiocyte Hypertrophy and Abnormal Intracellular Calcium-Handling

Background—Junctophilin-2 (JPH2), a protein expressed in the junctional membrane complex, is necessary for proper intracellular calcium (Ca2+) signaling in cardiac myocytes. Downregulation of JPH2 expression in a model of cardiac hypertrophy was recently associated with defective coupling between plasmalemmal L-type Ca2+ channels and sarcoplasmic reticular ryanodine receptors. However, it remains unclear whether JPH2 expression is altered in patients with hypertrophic cardiomyopathy (HCM). In addition, the effects of downregulation of JPH2 expression on intracellular Ca2+ handling are presently poorly understood. We sought to determine whether loss of JPH2 expression is noted among patients with HCM and whether expression silencing might perturb Ca2+ handling in a prohypertrophic manner. Methods and Results—JPH2 expression was reduced in flash-frozen human cardiac tissue procured from patients with HCM compared with ostensibly healthy traumatic death victims. Partial silencing of JPH2 expression in HL-1 cells by a small interfering RNA probe targeted to murine JPH2 mRNA (shJPH2) resulted in myocyte hypertrophy and increased expression of known markers of cardiac hypertrophy. Whereas expression levels of major Ca2+-handling proteins were unchanged, shJPH2 cells demonstrated depressed maximal Ca2+ transient amplitudes that were insensitive to L-type Ca2+ channel activation with JPH2 knockdown. Further, reduced caffeine-triggered sarcoplasmic reticulum store Ca2+ levels were observed with potentially increased total Ca2+ stores. Spontaneous Ca2+ oscillations were elicited at a higher extracellular [Ca2+] and with decreased frequency in JPH2 knockdown cells. Conclusions—Our results show that JPH2 levels are reduced in patients with HCM. Reduced JPH2 expression results in reduced excitation-contraction coupling gain as well as altered Ca2+ homeostasis, which may be associated with prohypertrophic remodeling.

[1]  W. Lederer,et al.  Excitation-contraction coupling changes during postnatal cardiac development. , 2010, Journal of molecular and cellular cardiology.

[2]  M. Bootman,et al.  Increased InsP3Rs in the junctional sarcoplasmic reticulum augment Ca2+ transients and arrhythmias associated with cardiac hypertrophy , 2009, Proceedings of the National Academy of Sciences.

[3]  B. Gersh,et al.  Expression Patterns of Cardiac Myofilament Proteins: Genomic and Protein Analysis of Surgical Myectomy Tissue From Patients With Obstructive Hypertrophic Cardiomyopathy , 2009, Circulation. Heart failure.

[4]  M. Ackerman,et al.  Molecular evolution of the junctophilin gene family. , 2009, Physiological genomics.

[5]  J. Seidman,et al.  Severe Heart Failure and Early Mortality in a Double-Mutation Mouse Model of Familial Hypertrophic Cardiomyopathy , 2008, Circulation.

[6]  A. Garfinkel,et al.  Effect of metabolic inhibition on couplon behavior in rabbit ventricular myocytes. , 2008, Biophysical journal.

[7]  S. McCulle,et al.  Hypertension-induced remodeling of cardiac excitation-contraction coupling in ventricular myocytes occurs prior to hypertrophy development. , 2007, American journal of physiology. Heart and circulatory physiology.

[8]  S. Ommen,et al.  Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans. , 2007, Journal of molecular and cellular cardiology.

[9]  O. Smithies,et al.  Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca release channel. , 2007, The Journal of clinical investigation.

[10]  Yasushi Kishimoto,et al.  Junctophilin‐mediated channel crosstalk essential for cerebellar synaptic plasticity , 2007, The EMBO journal.

[11]  H. Takeshima,et al.  Conformation-dependent Stability of Junctophilin 1 (JP1) and Ryanodine Receptor Type 1 (RyR1) Channel Complex Is Mediated by Their Hyper-reactive Thiols* , 2007, Journal of Biological Chemistry.

[12]  Gillian H. Little,et al.  Nuclear Calcium/Calmodulin-dependent Protein Kinase IIδ Preferentially Transmits Signals to Histone Deacetylase 4 in Cardiac Cells* , 2007, Journal of Biological Chemistry.

[13]  Yinhan Liu,et al.  Intermolecular Failure of L-type Ca2+ Channel and Ryanodine Receptor Signaling in Hypertrophy , 2007, PLoS biology.

[14]  H. Nakayama,et al.  Calcineurin‐dependent cardiomyopathy is activated by TRPC in the adult mouse heart , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  H. Takeshima,et al.  Uncoupling store-operated Ca2+ entry and altered Ca2+ release from sarcoplasmic reticulum through silencing of junctophilin genes. , 2006, Biophysical journal.

[16]  Eric A Sobie,et al.  Orphaned ryanodine receptors in the failing heart. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Tong Zhang,et al.  Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation-transcription coupling. , 2006, The Journal of clinical investigation.

[18]  Y. Ishikawa,et al.  Junctophilin type 2 is associated with caveolin-3 and is down-regulated in the hypertrophic and dilated cardiomyopathies. , 2004, Biochemical and biophysical research communications.

[19]  W. Claycomb,et al.  Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function. , 2004, American journal of physiology. Heart and circulatory physiology.

[20]  M. Nishi,et al.  Coexpression of junctophilin type 3 and type 4 in brain. , 2003, Brain research. Molecular brain research.

[21]  C. H. George,et al.  Ryanodine Receptor Mutations Associated With Stress-Induced Ventricular Tachycardia Mediate Increased Calcium Release in Stimulated Cardiomyocytes , 2003, Circulation research.

[22]  Steven R Houser,et al.  Is depressed myocyte contractility centrally involved in heart failure? , 2003, Circulation research.

[23]  Daniel Levy,et al.  Long-term trends in the incidence of and survival with heart failure. , 2002, The New England journal of medicine.

[24]  H. Takeshima,et al.  Deficiency of triad formation in developing skeletal muscle cells lacking junctophilin type 1 , 2002, FEBS letters.

[25]  M. Kano,et al.  Motor discoordination in mutant mice lacking junctophilin type 3. , 2002, Biochemical and biophysical research communications.

[26]  M. Croyle,et al.  Development of formulations that enhance physical stability of viral vectors for gene therapy , 2001, Gene Therapy.

[27]  M. Nishi,et al.  Deficiency of triad junction and contraction in mutant skeletal muscle lacking junctophilin type 1 , 2001, The Journal of cell biology.

[28]  C. Hansen,et al.  Alpha-1 adrenergic signaling in a cardiac murine atrial myocyte (HL-1) cell line , 2000, Molecular and Cellular Biochemistry.

[29]  M. Nishi,et al.  Characterization of human junctophilin subtype genes. , 2000, Biochemical and biophysical research communications.

[30]  M. Iino,et al.  Junctophilins: a novel family of junctional membrane complex proteins. , 2000, Molecular cell.

[31]  M. Esteban,et al.  Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): Mechanism of action , 2000, Apoptosis.

[32]  R. Winslow,et al.  Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, II: model studies. , 1999, Circulation research.

[33]  Jeffrey Robbins,et al.  A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy , 1998, Cell.

[34]  E. Erdmann,et al.  Calcium content of the sarcoplasmic reticulum in isolated ventricular myocytes from patients with terminal heart failure. , 1998, Journal of molecular and cellular cardiology.

[35]  W. Lederer,et al.  Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. , 1997, Science.

[36]  Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults: Echocardiographic Analysis of 4111 Subjects in the Cardia Study , 1996 .

[37]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[38]  T. Cocks,et al.  Pharmacological reactivity of human epicardial coronary arteries: phasic and tonic responses to vasoconstrictor agents differentiated by nifedipine , 1994, British journal of pharmacology.

[39]  N. Alpert,et al.  Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. , 1993, Circulation research.

[40]  D. Triggle,et al.  Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations. , 1991, Molecular pharmacology.

[41]  W Grossman,et al.  Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. , 1987, Circulation research.

[42]  M. Bechem,et al.  The optical isomers of the 1,4-dihydropyridine BAY K 8644 show opposite effects on Ca channels. , 1985, European journal of pharmacology.

[43]  W. Mckenna,et al.  The Natural History of Left Ventricular Hypertrophy in Hypertrophic Cardiomyopathy: An Electrocardiographic Study , 1982, Circulation.

[44]  C Liu,et al.  Characterization of ionomycin as a calcium ionophore. , 1978, The Journal of biological chemistry.

[45]  A. Grishman,et al.  New type of cardiomyopathy associated with diabetic glomerulosclerosis. , 1972, The American journal of cardiology.

[46]  E. Olson,et al.  signaling in cardiac myocyte excitation- transcription coupling , 2006 .

[47]  Michael D. Abràmoff,et al.  Image processing with ImageJ , 2004 .

[48]  L. McLain,et al.  Sudden death in young athletes. , 2003, Pediatric annals.

[49]  J. Schmitt,et al.  The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model. , 2002, The Journal of clinical investigation.

[50]  C. Ross,et al.  A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease–like 2 , 2001, Nature Genetics.

[51]  D. Kass,et al.  Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, I: experimental studies. , 1999, Circulation research.

[52]  G. Wang,et al.  Induction of the , 1996 .

[53]  W. Roberts,et al.  Causes of sudden death in competitive athletes. , 1986, Journal of the American College of Cardiology.